Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $28.3000 (-5.03%) ($28.0000 - $29.6000) on Thu. Dec. 8, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 39 | Latest Price | $28.3000(-5.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.8% a day on average for past five trading days. | Weekly Trend | CAPR declines -2.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) PEJ(7%) XLF(7%) ARKK(6%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.035% in a week (0% probabilities). TLT(-6%) GDX(-6%) VIXM(-5%) GLD(-5%) VCSH(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | 0 () | Intraday Trend | -4.4% | | | |
|
Resistance Level | $30.56 | 5 Day Moving Average | $29.94(-5.48%) | 10 Day Moving Average | $30.68(-7.76%) | 20 Day Moving Average | $30.56(-7.4%) | To recent high | -29.4% | To recent low | 6.4% | Market Cap | $557m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |